Cargando…
Clinical Experience with Perampanel in Intractable Focal Epilepsy Over 12 Months of Follow-Up
BACKGROUND AND PURPOSE: There are only limited studies on perampanel (PER), one of the latest antiepileptic drug. This study aimed to evaluate the long-term efficacy and tolerability of perampanel as an add-on therapy in patients with intractable focal epilepsy. METHODS: The medical records of 97 pa...
Autores principales: | Kim, Soo Yeon, Kim, Woo Joong, Kim, Hyuna, Choi, Sun Ah, Lim, Byung Chan, Chae, Jong-Hee, Kim, Ki Joong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Epilepsy Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6374530/ https://www.ncbi.nlm.nih.gov/pubmed/30809498 http://dx.doi.org/10.14581/jer.18010 |
Ejemplares similares
-
Adverse Events During Perampanel Adjunctive Therapy in Intractable Epilepsy
por: Youn, Song Ee, et al.
Publicado: (2018) -
Perampanel improved intractable myoclonus in two patients with myoclonus epilepsy
por: Iijima, Mutsumi, et al.
Publicado: (2019) -
The Role of Focal Epilepsy Features in Defining SCN1A Mutation-positive Dravet Syndrome as Generalized and Focal Epilepsy
por: Ko, Young Jun, et al.
Publicado: (2021) -
Paroxysmal Dyskinesia in Children: from Genes to the Clinic
por: Kim, Soo Yeon, et al.
Publicado: (2018) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023)